CAV2 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population of Homo sapiens origin, derived from the HeLa cervical adenocarcinoma line. The CAV2 gene has been disrupted to establish a loss-of-function model for caveolin-2, enabling detailed study of its roles in caveolae formation and signaling. This heterogeneous knockout pool avoids clonal artifacts and provides a robust system for functional analyses in membrane trafficking and signal transduction.
The HeLa host cell line, originally isolated from a cervical adenocarcinoma of Homo sapiens, is one of the most extensively characterized human cell lines in biomedical research. This HPV18-positive epithelial carcinoma line exhibits rapid proliferation and genetic tractability, making it ideal for CRISPR-based knockout generation. HeLa cells provide a well-defined background for studying oncogenic signaling, endocytosis, and viral protein interactions, with particular relevance to tumor biology and host?Cpathogen research.
Caveolin-2 (CAV2) is essential for caveolae assembly, working in concert with caveolin-1 (CAV1) to form plasma membrane invaginations that organize lipid raft domains and mediate clathrin-independent endocytosis. CAV2 transcription is controlled by upstream regulators p53, Egr-1, and HIF-1??. Once expressed, CAV2 oligomerizes with CAV1 and recruits eNOS and Src family kinases to caveolae. These structures facilitate internalization of growth factor receptors such as EGFR, subsequently activating the Ras?CERK1/2 cascade and STAT3 signaling. Knockout of CAV2 disrupts caveolar architecture, leading to diminished MAPK/ERK and STAT3 activation and consequent reductions in cell proliferation and migration.
Within the HeLa context, CAV2 knockout represents a specialized system for dissecting caveolin-dependent signaling pathways relevant to cervical adenocarcinoma. HeLa cells naturally express CAV1 and other caveolar proteins; thus, selective deletion of CAV2 permits examination of its unique contributions without completely ablating caveolae. This model is particularly suited for investigating caveolar endocytosis of growth factor receptors, integrin-mediated adhesion, and TGF-?? signaling, all of which may be modulated by HPV18 oncoproteins. Moreover, the polyclonal nature of the knockout population mirrors the genetic diversity of tumors, enhancing the applicability of findings to human cancer biology.
Research applications for this CAV2 knockout model span cancer biology, endocytosis kinetics, signal transduction pathways, and drug resistance mechanisms. Investigators can employ Western blotting to measure changes in ERK1/2 and STAT3 phosphorylation, immunofluorescence to assess caveolin-1 localization, and quantitative endocytosis assays to track receptor internalization. Functional assays such as wound healing, transwell migration, and invasion experiments reveal roles in cell motility, while proliferation assays evaluate growth dependencies. This polyclonal system reliably supports both mechanistic studies and drug discovery screens focusing on caveolin-dependent processes. For inquiries or to order, please contact Ascent Research.
